Last year, 10 early-career researchers from across the University of Oxford received a grant from the IOI and Oxford AMR Network, helping them build strong partnerships, share their work worldwide, and learn new skills to shape their research.
Read more about their work ➡️https://ow.ly/Mnnk50YOp0C
Sign and front entrance to the Life and Mind Building in summer. Credit: Brianna Cornock, 2025. Copyright © University of Oxford Images / Public Affairs Directorate -- All rights reserved.
EVENT: Oxford AMR Network on translation and commercialisation
Oxford researchers working on antimicrobial resistance are invited to hear from Oxford Science Enterprises and Oxford University Innovation, followed by networking.
📅 Tuesday 12 May, LaMB
👉 https://tinyurl.com/3nbz76jx
Antifungal resistance leads to >3.8 million deaths each year. To address this global threat, the IOI has established a new antifungal drug discovery programme, led by Dr Xuefei (Fei) Chen, to uncover new antifungal agents and treatments.
Find out more 👉https://ow.ly/SiAV50YMst9
Ineos Oxford Institute for antimicrobial research (IOI) at ESCMID Global 2026: Munich, Germany
Researchers from the IOI are presenting over 45 posters and talks at this year's ESCMID conference.
👉Explore the schedule of IOI presentations: https://ow.ly/i5JV50YIiLr
#ESCMID
Two global #AMR studies run by the IOI have finished collecting data, gathering 24,000 samples from 135,000 patients worldwide.
Analysis of these samples will continue in the UK, producing data that improves treatment, guide antibiotic use, and save lives.
Read more 👉 https://ow.ly/lnV350Yyaym
The Sheppard lab rocking at #MicroBio26 conference (Microbiology society annual conference 2026) at Belfast, UK
Come, find us, talk to us !
@microbiologysociety.org @ineosoxford.bsky.social @ox.ac.uk
Workshop attendees posing outdoors beside banner for data dissemination and analysis training in Nairobi, Kenya.
In February, the IOI hosted a scientific dissemination and data analysis workshop in Nairobi, bringing together collaborators from many African countries for discussions on #AMR, and to share how research shapes clinical practice and local engagement.
Read more👉https://ow.ly/1BUK50YH36C
At the 2026 IOI ECR conference >200 researchers from a range of disciplines came together in Oxford to share their #AMR work.
Dr Katy Thomson, scientific lead at the IOI, presented findings from the global surveillance study, BARNARDS.
Watch the full recording here➡️ youtu.be/oZ7upw9xPnI?...
#ICYMI
IOI researchers traced infections of Campylobacter, the no. 1 bacterial cause of diarrhoeal disease, back to their source — estimating that 80% came from poultry.
They recommend improved animal welfare on farms to control poultry-related infections.
Read more 👉 https://ow.ly/g0BG50YACs5
#ICYMI
IOI researchers have worked with Nigerian clinicians to gather >1,700 samples from 90 mother-baby pairs for one year after birth.
They will study how environmental factors affect the early-life bacterial and antibiotic exposures of Nigerian infants.
Read more 👉https://ow.ly/l0kq50YAGit
IOI’s Dr Alistair Farley speaks to BBC Discovery show about the development of new drugs and combination therapies to tackle antimicrobial resistance (#AMR). He discusses his work finding new inhibitor drugs to target resistance mechanisms in bacteria.
Listen here:https://ow.ly/81cu50YB4bA
Early career researchers are central to tackling #AMR, and we were delighted to host 200+ at our ECR conference last week.
As well as the speakers and participants, we would like to thank our ECR working group for their support.
Missed it? We’ll be sharing the talks soon https://ow.ly/AeZL50Yyy0x
Today is #WorldTBDay.
~500,000 people each year are infected with drug-resistant TB, and we need new drugs to fight this global threat.
At the IOI, chemists, biologists, clinicians, vaccinologists and health sociologists are working together to develop new therapies for TB.
IOI’s Dr Kirsty Sands speaks to BBC Discovery about the global impact of antimicrobial resistance (AMR). She highlights concerning findings that newborn babies in West Africa are already carrying antibiotic-resistant bacteria at birth.
Listen here: https://www.bbc.co.uk/sounds/play/w3ct6sxh
The #IOIECR26 conference has officially begun!
A huge thank you to everybody attending today, especially to all of our speakers and poster presenters sharing their #AMR research!
Researchers at the IOI developed a new method to pinpoint the "hidden" gene networks driving MRSA resistance. This AI-driven approach is 76% more accurate than standard models, it can establishes a predictive model for how different superbugs adapt over time.
👆Read more: https://ow.ly/3iY350YsQlm
IOI and Oxford Biology scientists estimate ~80% of Campylobacter infections are linked to poultry, and many are drug-resistant.
Campylobacter is the #1 bacterial cause of food poisoning. Cooking chicken well, and practicing good hygiene, prevents infection.
Read more👉 https://ow.ly/9ReF50Yty9O
📣We're pleased to announce our flash talk speakers for the 2026 IOI Early Career Researcher conference! #IOIECR26
🎓Join us in Oxford on 20 March to find out about their fantastic range of #AMR research
Read more➡️ www.ineosoxford.ox.ac.uk/event/ioi-early-career-r...
The IOI has launched the Campylobacter Control Campaign in The Gambia.
Led by Prof Sam Sheppard, a team of researchers from 19 countries will work together to develop vaccines for livestock to target campylobacter- the most common bacterial cause of diarrhoea.
👆Read more: https://ow.ly/X8uM50YtmPe
📣 Speaker alert! #IOIECR26
Our final keynote speaker for the 2026 ECR conference is the IOI's director, Prof Kevin Pethe.
💊Prof Pethe’s talk will focus on his work at the intersection of research and industry.
Read more about the ECR conference on our website ➡️https://ow.ly/4jfZ50Yrj0s
We kick-off the Campylobacter Control Campaign meeting with partners from @lshtm.bsky.social, @biology.ox.ac.uk, @ineosoxford.bsky.social, alongside collaborators from Côte d’Ivoire, #Nigeria, #Egypt, #Ghana & #BurkinaFaso to finalise a genomic sampling framework to support future vaccine designs.
📣 Speaker alert! #IOIECR26
Dr Katy Thomson from the IOI will present at our 2026 Early Career Researcher conference, sharing findings from our global neonatal sepsis and #AMR surveillance study, BARNARDS.
Find out more about the ECR conference➡️ https://ow.ly/CmUw50YrjR7
Dr Dorian Muntean built on his doctoral work on β-lactam antibiotics for SARS-CoV-2 to challenge current thinking on antimicrobial resistance, showing how antibiotic inhibitors bind to microbial enzyme targets in ways that could guide new drug development.
👆Read more : https://ow.ly/Ns6450YrbR2
🔬 University of Oxford studies found: point-of-care testing alone won't cut antibiotic prescribing for respiratory infections. It must be combined with clinical guidance, training & patient expectation management.
👆Full papers here: https://ow.ly/Nhok50Yq5bo
🧬 Researchers at the IOI have revealed that bacteria evolve through complex networks of genes rather than single mutations.
Going forward, this approach can support more effective strategies to limit the spread of antibiotic resistance.
👆Read the full paper: https://ow.ly/VVoW50Yow1m
📣 Speaker alert! #IOIECR26
Dr Daire Cantillon, Liverpool School of Tropical Medicine, will present at the IOI Early Career Researcher conference 2026, discussing how academia-industry links advance #AMR research.
Join us at the Saïd Business School in Oxford on 20 March ➡️https://ow.ly/TqG150YmRTQ
🚨Join us at the UK's largest Early Career Research Conference on AMR. Register through the link below before 5pm today to secure your free place!
🎓Our line-up of speakers will share their expertise on drug discovery, research translation, phages and fungi resistance.
🔗https://ow.ly/E8X450YmlLu
📣Prof Sam Sheppard has been elected as a Fellow of the American Academy of Microbiology.
The Academy is an honorific leadership group within the ASM that recognises excellence, originality, service and leadership in microbiolgy.
Learn more on our website👉https://ow.ly/6S7x50Yh4po
Sheppard Lab
📣 Speaker alert! #IOIECR26
Sid Mookerjee from the Brighton and Sussex Medical School will be speaking at our 2026 ECR conference, discussing AI tools and how they can be used for infection management. 🖥️
Join us at the Saïd Business School in Oxford on 20 March ️👉 https://ow.ly/2EPl50Yc8X5
🚨Two IOI antibiotic development programmes have joined the ENABLE-2 platform to develop new combination therapies to protect tetracycline antibiotics and a new class of beta-lactam antibiotics.
Read more👉https://ow.ly/y1pn50Yh5Bp
